THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
70 hedge funds and large institutions have $146M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more call options, than puts
Call options by funds: $117K | Put options by funds: $88K
11% more funds holding
Funds holding: 63 → 70 (+7)
Holders
70
Holding in Top 10
3
Calls
$117K
Puts
$88K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$4.49M | |
| 3 | +$2.5M | |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$1.17M |
| 5 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$1.12M |
Top Sellers
| 1 | -$4.62M | |
| 2 | -$3.27M | |
| 3 | -$1.64M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.18M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.08M |